Biotech · Private company · Boston, MA, US
Sensorium Therapeutics Inc
Track this companyFree. Adds Sensorium Therapeutics Inc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- A Drug Discovery Platform to Prioritize Development of Natural Product Neuromodulators for Treating Cognitive ImpairmentFiscal year 2025 · $1.5MNIH RePORTER 4R44AG085858-02 · fetched Nov 12, 2026
- A Drug Discovery Platform to Prioritize Development of Natural Product Neuromodulators for Treating Cognitive ImpairmentFiscal year 2024 · $502.5KNIH RePORTER 1R44AG085858-01 · fetched Nov 12, 2026